MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JK-19-0002746
Medilia Limited
Medilia Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4,277
▼ 86% YoY
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹125 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
7
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
About Medilia Limited
Data last updated:
Medilia Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PLC381855. Its GSTIN is 01AAOCM6494K1ZZ (Jammu and Kashmir).
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Harish Goyal and Pratik Pramod Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.37 Ground Floor Pocket N Sector – 5 Bawana Dsidc, Delhi, India – 110039.
As per MCA filings, the company has open charges of ₹125 Cr on record.
Medilia Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-19-0002746).
Company details
CIN U24299DL2021PLC381855
Registration Number 381855
Incorporation Date 03 June 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-JK-19-0002746
Recognitions & Rankings of Medilia
Contact details
Medilia Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.37 Ground Floor Pocket N Sector – 5 Bawana Dsidc, Delhi, India – 110039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medilia Limited, buy the company report.
Comprehensive company report
Medilia Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Medilia Limited
FY 2025 filings availableMedilia Limited reported revenue of ₹4,277 (down 86% YoY) for FY 2024.
Revenue · FY 2024
₹4,277 ▼ 86%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 86%
Revenue fell 86% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medilia Limited, buy the company report.
Board of directors of Medilia Limited
Medilia has 7 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Goyal Also directs: Niv Lifesciences LLP, Samson Laboratories Private Limited | Director | 03 Jun 2021 | 5 Years 5 Months | Current |
| Pratik Pramod Gupta Also directs: Proma Carbons Private Limited, Proma Greentech Private Limited, Vinpro Recycletech Private Limited and 3 more | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Gaurav Rajput | Director | 08 Dec 2021 | 4 Years 11 Months | Current |
| Anant Aggarwal Also directs: Yellow Ant Productions LLP, Viney Equity Market LLP, Yellow Ant Hospitality LLP and 5 more | Director | 08 Dec 2021 | 4 Years 11 Months | Current |
| Amarjyot Singh Anand Also directs: Techno Pet LLP, Hindustan Closures Private Limited | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Akshay Pramod Gupta Also directs: Shivam Syncotex Private Limited, Sonpankhi Shares and Securities Private Limited, Proma Carbons Private Limited and 4 more | Director | 01 Jun 2024 | 2 Years 5 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Medilia Limited is audited by AHPN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AHPN & ASSOCIATES | FY 2023 | 09452N |
Shareholding
The shareholding of Medilia Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Medilia Limited, buy the company report.
Charges & borrowings
Open charges
₹125 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jul 2024 | 100960163 | Axis Bank Limited | ₹125 Cr | Open |
To see the full charge records of Medilia Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medilia Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medilia Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medilia Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Medilia has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAOCM6494K1ZZ | Jammu and Kashmir | Active | 06 Apr 2022 |
To see the full GST registrations and return filing status of Medilia Limited, buy the company report.
Recent activity
Medilia Limited has 16 board changes on record since 2021: 7 appointments and 9 cessations. The latest: Kayan Sharma was appointed as Additional Director on 12 Sep 2025.
Charges
A charge with Axis Bank Limited of Rs. 125.00 Cr registered on 02 Jul 2024 with Charge ID 100960163 was modified on 29 Jan 2026.
AGM
Medilia Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Kayan Sharma was appointed as Additional Director.
Filing
Medilia Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Akshay Pramod Gupta ceased to be Additional Director.
Ceased
Amarjyot Singh Anand ceased to be Additional Director.
Ceased
Pratik Pramod Gupta ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 125.00 Cr with Charge ID 100960163 was registered on 02 Jul 2024.
Appointed
Akshay Pramod Gupta was appointed as Director.
Appointed
Amarjyot Singh Anand was appointed as Director.
Appointed
Pratik Pramod Gupta was appointed as Director.
Ceased
Anant Aggarwal ceased to be Additional Director.
9 earlier events are in the company report.
Frequently asked questions
Medilia is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 June 2021 (5+ years old) and is registered under CIN U24299DL2021PLC381855.
Medilia has 7 current directors:
- Harish Goyal - Director
- Pratik Pramod Gupta - Director
- Gaurav Rajput - Director
- Anant Aggarwal - Director
- Amarjyot Singh Anand - Director
- Akshay Pramod Gupta - Director
- Kayan Sharma - Additional Director
The latest financial statements of Medilia on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medilia is 01AAOCM6494K1ZZ, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Medilia is U24299DL2021PLC381855. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilia was incorporated on 03 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Kayan Sharma was appointed as Additional Director on 12 Sep 2025. Akshay Pramod Gupta ceased to be Additional Director on 29 Nov 2024. Amarjyot Singh Anand ceased to be Additional Director on 29 Nov 2024. Medilia has 16 board changes on record in total.
Yes, Medilia is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-19-0002746).
The registered office of Medilia is at Plot No.37 Ground Floor Pocket N Sector – 5 Bawana Dsidc, Delhi, India – 110039.
Medilia operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages